SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Radiant Creations Group Inc (OTCBB:RCGP) has widely been regarded as one of those companies that should not be invested in. Some of the investors have put aside the concerns of experts and fell for the hype created by the company. There has been a significant rise in the stock value of the company, with the only reason being flow of investment from the market. The company had been stuck at the triple zero mark for a very long time, but recent investments helped the share make a number of jumps.

The rise in the stock price may seem like a good sign for the penny traders, but it is not expected to last long. According to the experts, the financial report of the company and lack of news about any developments is a bad sign. It may be assumed that the company is going in substantial loss and may eventually end bankrupt. The financial report indicated cash of $4 thousand and a net loss of $1.4 million.

It is mainly up to the company to change its fortunes by making some good decisions. This amount alone is more than what the company has had available in cash. Investing it in the right products and services may give the company an extended run to finally sort things out.

It has been a long and rough year for the company, especially the quarter ending as of November 2014. The CEO of the company predicted generation of $1.9 million in revenues, but the financial report for the same quarter indicated just about $70 thousand from revenues.

The company recently made the right call to increase its authorized shares by $900 million, which has given it the benefit to get more from the investors. It is all now just a waiting game, to see if the company releases any news about latest projects that might help the company financially.

SHARE
Previous articlePervasip Corp (OTCMKTS:PVSP) Rising What Should Be the Next Step?
Next articleMedbox Inc (OTCMKTS:MDBX) FY2014 Revenue Declines 69% YOY
Steve Kanaval: Portfolio Manager/Writer/ Market Analyst Steve began his career in the Trading Pits in Chicago making markets at the Chicago Mercantile Exchange (NYSE:CME) the Chicago Board of Trade and the CBOE in the early 80’s. He ran the Morgan Stanley Derivative Prop Trading for the firm specializing in Index Arbitrage. He continued his career as a Trader/Portfolio Manager for multiple Hedge Funds during the Internet Boom of the 90’s managing large portfolios. Steve is known as an expert in MicroCap Technology Stocks and the emerging Digital Currency markets as a Portfolio Manager for his Family Office. Steve has managed portfolio’s in volatile asset classes for 3 decades as a commodity trader, hedge fund manager and digital currency trader and miner. Steve publishes his views on the asset classes in a public forum and has published more than 10,000 articles simplifying these complex and volatile assets for readers. His work is published on multiple sites including Bloomberg, Equities.com, Hacked.com, CryptoCurrencyNews as a paid contributor. His work includes research, journalism and archived video on important market volatility related to stocks, digital currency and other volatile misunderstood asset classes. He offers a humorous, unique insight and the related back stories and drivers for readers interested in volatility and emerging market assets. Full disclosure Steve is long 25 digital currencies and sits on the board of multiple public companies involved in digital currencies, and owns shares in these companies from time to time.